, Tracking Stock Market Picks
Enter Symbol:
Icad Inc. (ICAD) [hlAlert]

up 40.00 %

Icad Inc. (ICAD) rated Buy with price target $4 by Sun Trust Rbsn Humphrey

Posted on: Thursday,  Feb 14, 2008  8:25 AM ET by Sun Trust Rbsn Humphrey

Sun Trust Rbsn Humphrey rated Buy Icad Inc. (NASDAQ: ICAD) on 02/14/2008, when the stock price was $2.70.
Since then, Icad Inc. has gained 40.00% as of 11/24/2015's recent price of $3.78.
If you would have followed this Sun Trust Rbsn Humphrey's recommendation on ICAD, you would have gained 40% of your investment in 2840 days.

iCAD, Inc. (iCAD) is a provider of computer-aided detection system (CAD) solutions that enable radiologists and other healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier. CAD is performed as an adjunct to mammography screening. CAD is also reimbursable in the United States under federal and third party insurance programs. iCAD is also developing CAD solutions for use with virtual colonoscopy to improve the detection of colonic polyps while delivering improved workflow for the radiologists, and higher quality patient care. In July 2008, the Company acquired pharmaco-kinetic based CAD products that aid in the interpretation of contrast enhanced MRI images of the breast and prostate.

We provide equity research coverage on more than 300 companies in select core industries and sub-sectors with above-average growth potential. Our focused approach allows our analysts to have deep knowledge of industries, companies and markets they cover, enabling them to deliver highly insightful research and sound advice. With our expertise and thoughtful, diligent approach, our equity research positions you to make well-informed decisions that contribute to your success.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/14/2008 8:25 AM Buy
2.70 4.00
as of 12/24/2008
1 Week up  11.11 %
1 Month up  17.02 %
3 Months down  -12.69 %
1 YTD down  -2.65 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy